Projected upregulations were observed in the adipokine LRG1 (Leucine-rich alpha-2-glycoprotein 1) associated with liver diseases, notably in obesity-induced hepatosteatosis and insulin resistance. This evidence concerns the gene LRG1 and liver disorder.